AXIS SPINE TECHNOLOGIES LTD

Active Reading

Other research and experimental development on natural sciences and engineering

9 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
A

AXIS SPINE TECHNOLOGIES LTD

Other research and experimental development on natural sciences and engineering

Founded 20 Jul 2016 Active Reading, United Kingdom 9 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering

Previous Company Names

BRIDGING BONE LIMITED 20 Jul 2016 — 20 Jun 2018
Accounts Submitted 29 Aug 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 30 Mar 2026 Next due 22 Mar 2027 9 months remaining
Net assets £5M £4M 2023 year on year
Total assets £5M £4M 2023 year on year
Total Liabilities £540K £233K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

1st Floor West Davidson House Forbury Square Reading Berkshire RG1 3EU United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for AXIS SPINE TECHNOLOGIES LTD (10287664), an active life sciences and medical technology company based in Reading, United Kingdom. Incorporated 20 Jul 2016. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2017–2023)

Cash in Bank

£4.77M

Increased by £4.44M (+1356%)

Net Assets

£4.76M

Increased by £3.71M (+355%)

Total Liabilities

£539.67k

Increased by £233.21k (+76%)

Turnover

N/A

Employees

9

Increased by 2 (+29%)

Debt Ratio

10%

Decreased by 13 (-57%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Jul Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 1

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 7Apr 2020Unknown/Other
Investor 4Jan 2021Unknown/Other
Investor 5Jan 2021Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

41 Allotments 177,543 Shares £23.42m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 Feb 2026124£1.24£0.01
19 Jun 2025549£114k£207.56
12 May 2025720£149k£207.56
9 Apr 20256,985£1.45m£207.56
9 Apr 20254,910£1.02m£207.56

Officers

Officers

3 active
Status
Alex Stephen GwytherDirectorBritishEngland3525 Apr 2024Active
Cartmell, Simon ChristopherDirectorBritishUnited Kingdom665 Feb 2021Active
Ogilvie, StephanDirectorAmericanUnited States4917 Oct 2022Active

Shareholders

Shareholders (61)

Mercia (general Partner) Ltd
10.3%
14,454
Biotex Medical Device Fund I, Lp
10.3%
14,454

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased
Ceased

Jonathan Arcos

Ceased 27 Jan 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 May 2026IncorporationMemorandum Articles
14 May 2026CapitalCapital Cancellation Shares
14 May 2026ResolutionResolutions
24 Apr 2026CapitalAllotment of shares (GBP 1,460.7905) on 23 Apr 2026
30 Mar 2026Confirmation StatementConfirmation statement made on 8 Mar 2026 with updates
14 May 2026 Incorporation

Memorandum Articles

14 May 2026 Capital

Capital Cancellation Shares

14 May 2026 Resolution

Resolutions

24 Apr 2026 Capital

Allotment of shares (GBP 1,460.7905) on 23 Apr 2026

30 Mar 2026 Confirmation Statement

Confirmation statement made on 8 Mar 2026 with updates

Recent Activity

Latest Activity

Memorandum Articles

2 weeks ago on 14 May 2026

Capital Cancellation Shares

2 weeks ago on 14 May 2026

Resolutions

2 weeks ago on 14 May 2026

Allotment of shares (GBP 1,460.7905) on 23 Apr 2026

1 months ago on 24 Apr 2026

Confirmation statement made on 8 Mar 2026 with updates

2 months ago on 30 Mar 2026